Renaissance Technologies
CODX

Renaissance Technologies’s Co-Diagnostics CODX Stock Holding History

Renaissance Technologies’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.8K Buy
+12,500
New +$38.5K ﹤0.01% 3063
2026
Q1 		– Sell
-24,344
Closed -$123K – 3317
2025
Q4 		$123K Sell
24,344
-4,573
-16% -$49.8K ﹤0.01% 2973
2025
Q3 		$298K Buy
28,917
+10,216
+55% +$95K ﹤0.01% 3000
2025
Q2 		$157K Buy
18,701
+357
+2% +$3.34K ﹤0.01% 3211
2025
Q1 		$170K Sell
18,344
-177
-1% -$3.38K ﹤0.01% 3109
2024
Q4 		$417K Sell
18,521
-403
-2% -$12.7K ﹤0.01% 2925
2024
Q3 		$710K Sell
18,924
-643
-3% -$24.7K ﹤0.01% 2626
2024
Q2 		$734K Sell
19,567
-446
-2% -$16.2K ﹤0.01% 2494
2024
Q1 		$672K Sell
20,013
-554
-3% -$20.1K ﹤0.01% 2729
2023
Q4 		$821K Sell
20,567
-646
-3% -$22.8K ﹤0.01% 2528
2023
Q3 		$675K Sell
21,213
-577
-3% -$21.8K ﹤0.01% 2563
2023
Q2 		$726K Buy
21,790
+180
+0.8% +$6.89K ﹤0.01% 2674
2023
Q1 		$959K Sell
21,610
-197
-0.9% -$15.8K ﹤0.01% 2508
2022
Q4 		$1.65M Sell
21,807
-1,686
-7% -$158K ﹤0.01% 2198
2022
Q3 		$2.26M Buy
23,493
+710
+3% +$99.3K ﹤0.01% 1935
2022
Q2 		$3.83M Buy
22,783
+3,248
+17% +$494K ﹤0.01% 1751
2022
Q1 		$3.62M Buy
19,535
+9,718
+99% +$2.01M ﹤0.01% 1804
2021
Q4 		$2.63M Buy
9,817
+3,667
+60% +$962K ﹤0.01% 1942
2021
Q3 		$1.79M Buy
6,150
+4,107
+201% +$1.2M ﹤0.01% 2170
2021
Q2 		$506K Buy
+2,043
New +$525K ﹤0.01% 2962
2020
Q1 		– Sell
-534
Closed -$14K – 3478
2019
Q4 		$14K Buy
+534
New +$15.7K ﹤0.01% 3457

Other funds holding CODX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAG
Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies's CODX Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Co-Diagnostics (CODX) in Q2 2026: 12,500 shares worth $38.8K. The stake represents ﹤0.01% of the portfolio and ranks #3063 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in CODX as recently as Q4 2025.

Renaissance Technologies first reported a position in CODX in Q4 2019 and has held it in 21 quarters since. The position peaked at $3.83M in Q2 2022. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

  • Renaissance Technologies held 12,500 shares of Co-Diagnostics worth $38.8K as of Q2 2026.
  • Co-Diagnostics was a new Renaissance Technologies position in Q2 2026.
  • Co-Diagnostics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3063 holding.
  • Renaissance Technologies first reported a position in Co-Diagnostics in Q4 2019 and has held it in 21 quarters since.
  • Renaissance Technologies's Co-Diagnostics position peaked at $3.83M in Q2 2022.
  • 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.